The antibody portion of<unk> <unk>  binds to and forms a complex with tissue factor, a molecule expressed on the surface of cancer cells. This complex is then taken up into the cell, where<unk>  is broken down by proteolytic cleavage, releasing MMAE, which stops the cell cycle and kills the cell by apoptosis.
Tisotumab vedotin
Sacituzumab govitecan
Enfortumab vedotin
Bezlotoxumab
Teprotumumab
Tralokinumab
Lanadelumab
Alirocumab